179 related articles for article (PubMed ID: 8578845)
1. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles.
Vordermeier HM; Coombes AG; Jenkins P; McGee JP; O'Hagan DT; Davis SS; Singh M
Vaccine; 1995 Nov; 13(16):1576-82. PubMed ID: 8578845
[TBL] [Abstract][Full Text] [Related]
2. Protective efficacy of mycobacterial 71-kDa cell wall associated protein using poly (DL-lactide-co-glycolide) microparticles as carrier vehicles.
Dhiman N; Khuller GK
FEMS Immunol Med Microbiol; 1998 May; 21(1):19-28. PubMed ID: 9657317
[TBL] [Abstract][Full Text] [Related]
3. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
[TBL] [Abstract][Full Text] [Related]
4. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Lavelle EC; Yeh MK; Coombes AG; Davis SS
Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
[TBL] [Abstract][Full Text] [Related]
5. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles.
Yeh MK; Liu YT; Chen JL; Chiang CH
J Control Release; 2002 Aug; 82(2-3):237-47. PubMed ID: 12175740
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of Mycobacterium tuberculosis infections in mice with a combination of isoniazid and rifampicin entrapped in Poly (DL-lactide-co-glycolide) microparticles.
Dutt M; Khuller GK
J Antimicrob Chemother; 2001 Jun; 47(6):829-35. PubMed ID: 11389115
[TBL] [Abstract][Full Text] [Related]
7. Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination.
Yeh M; Chiang C
J Microencapsul; 2004 Feb; 21(1):91-106. PubMed ID: 14718189
[TBL] [Abstract][Full Text] [Related]
8. Vaccine properties of antigens entrapped in microparticles produced by spray-drying technique and using various polyester polymers.
Baras B; Benoit M; Poulain-Godefroy O; Schacht A; Capron A; Gillard J; Riveau G
Vaccine; 2000 Feb; 18(15):1495-505. PubMed ID: 10618547
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant Potential of Poly-α-l-Glutamine from the Cell Wall of Mycobacterium tuberculosis.
Mani R; Gupta M; Malik A; Tandon R; Prasad R; Bhatnagar R; Banerjee N
Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30104212
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant modulation of T-cell reactivity to 30-kDa secretory protein of Mycobacterium tuberculosis H37Rv and its protective efficacy against experimental tuberculosis.
Sharma AK; Verma I; Tewari R; Khuller GK
J Med Microbiol; 1999 Aug; 48(8):757-763. PubMed ID: 10450999
[TBL] [Abstract][Full Text] [Related]
11. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
Partidos CD; Vohra P; Jones D; Farrar G; Steward MW
J Immunol Methods; 1997 Aug; 206(1-2):143-51. PubMed ID: 9328577
[TBL] [Abstract][Full Text] [Related]
12. T- and B-cell epitopes in the secreted Mycobacterium bovis antigen MPB70 in mice.
Tollefsen S; Pollock JM; Lea T; Harboe M; Wiker HG
Scand J Immunol; 2003 Feb; 57(2):151-61. PubMed ID: 12588661
[TBL] [Abstract][Full Text] [Related]
13. Diaminosulfide based polymer microparticles as cancer vaccine delivery systems.
Geary SM; Hu Q; Joshi VB; Bowden NB; Salem AK
J Control Release; 2015 Dec; 220(Pt B):682-90. PubMed ID: 26359124
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protective efficacy of a tuberculosis DNA vaccine by adsorption onto cationic PLG microparticles.
Mollenkopf HJ; Dietrich G; Fensterle J; Grode L; Diehl KD; Knapp B; Singh M; O'Hagan DT; Ulmer JB; Kaufmann SH
Vaccine; 2004 Jul; 22(21-22):2690-5. PubMed ID: 15309815
[TBL] [Abstract][Full Text] [Related]
15. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
Moore A; McGuirk P; Adams S; Jones WC; McGee JP; O'Hagan DT; Mills KH
Vaccine; 1995 Dec; 13(18):1741-9. PubMed ID: 8701587
[TBL] [Abstract][Full Text] [Related]
16. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
Men Y; Gander B; Merkle HP; Corradin G
Vaccine; 1996 Oct; 14(15):1442-50. PubMed ID: 8994320
[TBL] [Abstract][Full Text] [Related]
17. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
O'Hagan DT; Jeffery H; Davis SS
Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845
[TBL] [Abstract][Full Text] [Related]
18. Chitosan microspheres enhance the immunogenicity of an Ag85B-based fusion protein containing multiple T-cell epitopes of Mycobacterium tuberculosis.
Zhu Bd; Qie Yq; Wang Jl; Zhang Y; Wang Qz; Xu Y; Wang Hh
Eur J Pharm Biopharm; 2007 Jun; 66(3):318-26. PubMed ID: 17280823
[TBL] [Abstract][Full Text] [Related]
19. Dependence of ricin toxoid vaccine efficacy on the structure of poly(lactide-co-glycolide) microparticle carriers.
Yan C; Rill WL; Malli R; Hewetson J; Tammariello R; Kende M
Vaccine; 1995 May; 13(7):645-51. PubMed ID: 7668034
[TBL] [Abstract][Full Text] [Related]
20. Biodegradable microparticles for the mucosal delivery of antibacterial and dietary antigens.
Fattal E; Pecquet S; Couvreur P; Andremont A
Int J Pharm; 2002 Aug; 242(1-2):15-24. PubMed ID: 12176221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
